Affiliation:
1. From Lenox Hill Hospital, New York City, NY.
Abstract
Carotid artery stenting, compared with carotid endarterectomy, is emerging as an effective and less invasive method of revascularization for extracranial carotid artery stenosis. Carotid stenting is established as the treatment of choice for certain high-risk patient subsets, and ongoing clinical trials are evaluating this method across a broader clinical spectrum, including asymptomatic patients. For carotid stenting to reach its full potential, an acceptable risk of periprocedural complications, particularly in low-risk patients, must be ensured (the “3% rule”). The present article provides an in-depth review of carotid stenting, with special emphasis on the process of risk stratification pertaining to clinical, anatomic, and procedural considerations necessary to optimize procedural safety and patient outcomes.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference57 articles.
1. Gray WA. The ARCHeR trials: final one year results. Presented at: Annual American College of Cardiology Scientific Sessions; March 7 2004; New Orleans La.
2. Withlow P. Registry study to evaluate the Neuroshield Bare-Wire Cerebral Protection System and X-Act Stent in patients at high risk for carotid endarterectomy (SECuRITY]). Presented at: Annual Transcatheter Therapeutics Scientific Sessions; September 17 2003; Washington DC.
3. Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
4. Endarterectomy for Asymptomatic Carotid Artery Stenosis
Cited by
156 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献